J. Paul Santerre, Ph.D. (Biomaterials)
Professor of Biomaterials and Director of the Institute for Biomaterials and Biomedical Engineering at the University of Toronto. Founder of Interface Biologics Inc., in 2001.
Nicolas Chronos, M.D. (Interventional Cardiology)
Chief Medical and Scientific Officer, Saint Joseph’s Research Institute, Atlanta; Director of 90+ pre-clinical & clinical trials.
John Denstedt, M.D. (Urology)
Urologist and Chairman of the Department of Surgery at The University of Western Ontario; author of over 200 scientific articles and book chapters.
Tony Khoury, M.D. (Urology)
Chief of Pediatric Urology at CHOC and UC Irvine Medical Center; Former Chief of Paediatric Urology at The Hospital for Sick Children; Professor of Surgery at the University of Toronto.
Rosalind Labow, Ph.D. (Biochemistry)
Director, Taichman Laboratory, University of Ottawa Heart Institute; Professor, Department of Surgery and Departments of Biochemistry, Microbiology and Immunology, University of Ottawa.
Marc W. Mittelman, Ph.D. (Microbiology)
Professor of Microbiology at Bristol College, Boston, MA; Visiting Professor at Laboratory of Applied Microbiology at Harvard University.
J. Curtis Nickel, M.D. (Urology)
Professor of Urology at Queen’s University in Kingston, ON; Canada Research Chair in Urologic Pain and Inflammation.
Leonard Pinchuk, Ph.D. (Biomaterials)
Co-founder and President/CEO of Innovia and its affiliates; world-renowned expert in the field of biomaterials and medical devices with over 80 patents in this area.
Robert Schwartz, M.D. (Interventional Cardiology)
Medical Director, Minneapolis Heart Institute Foundation, Professor of Medicine, University of Minnesota and Cardiologist, Minneapolis Heart Institute.
Bradley Strauss, M.D. (Interventional Cardiology)
Chairman, Cardiovascular Research Sunnybrook Health Sciences Centre; Reichmann Research Chair in Cardiovascular Sciences at the University of Toronto.